Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Akorn Inc. News

Generic-Drug Maker Akorn Files Chapter 11

Generic-drug maker Akorn filed a Chapter 11 petition. A deal with its lenders will enable it to continue a search for a buyer.

Drugmaker Akorn Receives FDA Warning Letter Regarding N.J. Facility

Akorn receives a warning letter from the U.S. Food & Drug Administration regarding an inspection of the company's facility in Somerset, New Jersey.

Dow Loses Steam as Yields Hover Near 3% Threshold

The S&P 500 finished slightly higher, up just 0.01%.

Akorn's Stock Crashes as Germany's Fresenius Ends Takeover Amid Data Allegations

Akorn shares plummeted Monday after Germany's Fresenius Medical ditched its planned $5 billion takeover amid allegations of data misconduct at the Lake Forest, Ill.-based generic drugmaker.

Alphabet Earnings and 4 Other Business Stories You Must Know Monday Morning

Happy Monday! These are the headlines you need to see during your morning commute.

Breaking News

FTX Reportedly Close to Buying BlockFi

An acquisition could take several months to close, and the price could shift between now and Friday.

Morningstar's Five Coping Mechanisms for Bear Market

The S&P 500 is in a bear market, having lost 20% so far this year. So what’s an investor to do?

Economist Roubini: Why Stocks Poised for 50% Wipeout

The stock market is off to its worst start to a year since 1962, with the S&P 500 dropping 21% in the first half of 2022.

Who Is the Mystery Crypto Queen on the Run After an Alleged Scam?

The FBI is offering anyone who helps arrest OneCoin co-founder Dr. Ruja Ignatova $100,000.